NCT00170378

The Use of Low Molecular Weight Heparin in Traumatic Brain Injury

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 300 (planned)
• Sponsor: Hennepin Healthcare Research Institute · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

To study the safety and efficacy of early administration of Low Molecular Weight Heparin to patients with traumatic brain injury.

Detailed description

Venous thromboembolic (VTE) prophylaxis in trauma patients is a critical clinical problem. Patients with traumatic brain injury usually have effective VTE prophylaxis withheld secondary to concerns of exacerbating intracranial hemorrhage. This study examines the safety and efficacy of early administration (within 24 hrs of admission) of low molecular weight heparin to this patient population with very high VTE risk.

Conditions

• Brain Injury
• Venous Thrombosis

Interventions

Type	Name	Description
DRUG	Enoxaparin

Timeline

• Start date: 2002-12-01
• Completion: 2005-08-01
• First posted: 2005-09-15
• Last updated: 2017-06-27

Locations

1 site across 1 country: United States